Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;34(3):117-124.
doi: 10.1053/j.semvascsurg.2021.08.001. Epub 2021 Aug 9.

COVID-19-associated venous thromboembolism portends worse survival

Richard A Meena  1 , Milad Sharifpour  2 , Manila Gaddh  2 , Xiangqin Cui  3 , Yue Xie  2 , Mengyu Di  2 , Luke P Brewster  3 , Yazan Duwayri  2 , Olamide Alabi  3
Affiliations

COVID-19-associated venous thromboembolism portends worse survival

Richard A Meena et al. Semin Vasc Surg. 2021 Sep.

Abstract

Patients with coronavirus disease 2019 (COVID-19) seem to be at high risk for venous thromboembolism (VTE) development, but there is a paucity of data exploring both the natural history of COVID-19-associated VTE and the risk for poor outcomes after VTE development. This investigation aims to explore the relationship between COVID-19-associated VTE development and mortality. A prospectively maintained registry of patients older than 18 years admitted for COVID-19-related illnesses within an academic health care network between March and September 2020 was reviewed. Codes from the tenth revision of the International Classification of Diseases for VTE were collected. The charts of those patients with a code for VTE were manually reviewed to confirm VTE diagnosis. There were 2,552 patients admitted with COVID-19-related illnesses. One hundred and twenty-six patients (4.9%) developed a VTE. A disproportionate percentage of patients of Black race developed a VTE (70.9% VTE v 57.8% non-VTE; P = .012). A higher proportion of patients with VTE expired during their index hospitalization (22.8% VTE v 8.4% non-VTE; P < .001). On multivariable logistic regression analysis, VTE was independently associated with mortality (odds ratio = 3.17; 95% confidence interval, 1.9-5.2; P < .001). Hispanic/Latinx ethnicity was associated with decreased mortality (odds ratio = 0.45; 95% confidence interval, 0.21-1.00; P = .049). Hospitalized patients of Black race with COVID-19 were more prone to VTE development, and patients with COVID-19 who developed in-hospital VTE had roughly nearly threefold higher odds of mortality. Further emphasis should be placed on optimizing COVID-19 anticoagulation protocols to reduce mortality in this high-risk cohort.

Keywords: Anticoagulation; COVID-19; VTE; Vascular Surgery; antithrombotic; mortality; vascular medicine; venous thromboembolism.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
Flowchart illustrating delineation of venous thromboembolism (VTE) cohort. COVID-19, coronavirus disease 2019.
Fig 2
Fig. 2
Forest plot demonstrating risk factors associated with mortality on multivariable analysis. ICU, intensive care unit; VTE, venous thromboembolism.
See this image and copyright information in PMC

References

    1. Bikdeli B, Madhavan MV, Jimenez D, et al. Global COVID-19 Thrombosis Collaborative Group. COVID-19 and Thrombotic or Thromboembolic Disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75:2950–2973. - PMC - PubMed
    1. Costanzo L, Palumbo FP, Ardita G, et al. Italian Society for Vascular Investigation and the Italian Society of Vascular Medicine. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia. J Vasc Surg Venous Lymphat Disord. 2020;8:711–716. - PMC - PubMed
    1. Middeldorp S, Coppens M, van Haaps TF, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18:1995–2002. - PMC - PubMed
    1. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–147. - PMC - PubMed
    1. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135:2033–2040. - PMC - PubMed